Search
  • Contact Us
  • Careers
Menu
  • Contact Us
  • Careers
Applied Therapeutics logo
  • About Us
    • Leadership
      • Executive Leadership
      • Board of Directors
      • Scientific Advisory Board
    • Mission
    • Culture
    • Contact
  • Pipeline
    • AT-007
    • AT-001
    • AT-003
    • AT-104
    • Clinical Trials
  • Patients & Caregivers
    • Galactosemia
    • SORD Deficiency
    • PMM2-CDG
    • Diabetic Cardiomyopathy
    • T-ALL
    • Advocacy & Engagement
  • Investors & Media
    • Stock Info
    • Financial Info
    • Corporate Governance
    • Events
    • Press Releases
    • Presentations & Publications
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • Investor Contacts
Applied Therapeutics logo
Applied Therapeutics logo
  • About Us
    • Leadership
      • Executive Leadership
      • Board of Directors
      • Scientific Advisory Board
    • Careers
    • Mission
    • Culture
      • Diversity & Inclusion
    • Contact Us
  • Pipeline
    • AT-007
    • AT-001
    • AT-003
    • AT-104
    • Clinical Trials
  • Patients & Caregivers
    • Understanding Diabetic Cardiomyopathy
    • Understanding Galactosemia
    • SORD Deficiency
    • PMM2-CDG
    • T-ALL
    • Advocacy & Engagement
  • Investors & Media
    • Stock Info
    • Financial Info
    • Corporate Governance
    • Events
    • Press Releases
    • Presentations & Publications
    • Investor FAQs
    • Email Alerts
    • Investor Contacts
Applied Therapeutics logo
Board of Directors
Board of Director Joel Marcus

Joel Marcus

Board of Director Jay Skyler

Jay Skyler

Board of Director Stacy Kanter

Stacy Kanter

Board of Director Les Funtleyder

Les Funtleyder

Board of Director Teena Lerner

Teena Lerner

CEO & Founder Shoshana Shendelman

Shoshana Shendelman

Chair, Board of Directors

Leadership

  • Executive Leadership
  • Board of Directors
  • Scientific Advisory Board
Menu
  • Executive Leadership
  • Board of Directors
  • Scientific Advisory Board

In the about us section

BehindBottomNav-SmallerSwoosh-min
Swoosh Background-min
Leadership
Mission
Culture
Contact
Applied Therapeutics logo
  • About Us
  • Pipeline
  • Patients & Caregivers
  • Investors & Media
Menu
  • About Us
  • Pipeline
  • Patients & Caregivers
  • Investors & Media
  • Terms of Use
  • Privacy Policy
Linkedin Facebook-square Twitter-square

©2020 Applied Therapeutics All Rights Reserved

Linkedin Facebook-square Twitter-square
  • About Us
    • Leadership
      • Executive Leadership
      • Board of Directors
      • Scientific Advisory Board
    • Mission
    • Culture
    • Contact
  • Pipeline
    • AT-007
    • AT-001
    • AT-003
    • AT-104
    • Clinical Trials
  • Patients & Caregivers
    • Galactosemia
    • SORD Deficiency
    • PMM2-CDG
    • Diabetic Cardiomyopathy
    • T-ALL
    • Advocacy & Engagement
  • Investors & Media
    • Stock Info
    • Financial Info
    • Corporate Governance
    • Events
    • Press Releases
    • Presentations & Publications
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • Investor Contacts
Menu
  • About Us
    • Leadership
      • Executive Leadership
      • Board of Directors
      • Scientific Advisory Board
    • Mission
    • Culture
    • Contact
  • Pipeline
    • AT-007
    • AT-001
    • AT-003
    • AT-104
    • Clinical Trials
  • Patients & Caregivers
    • Galactosemia
    • SORD Deficiency
    • PMM2-CDG
    • Diabetic Cardiomyopathy
    • T-ALL
    • Advocacy & Engagement
  • Investors & Media
    • Stock Info
    • Financial Info
    • Corporate Governance
    • Events
    • Press Releases
    • Presentations & Publications
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • Investor Contacts
  • Terms of Use
  • Privacy Policy
Applied Therapeutics logo

©2020 Applied Therapeutics All Rights Reserved